Paul Fonteyne was appointed President and CEO of Boehringer Ingelheim USA Corp. and US Country Managing Director on January 1, 2012. In addition, he is President of the US Human Pharmaceutical Business. Paul has been employed by Boehringer Ingelheim since 2003. Leading up to this role, Paul was responsible for Global Marketing of BI’s pharmaceutical business, and before that its pharmaceutical business in the US.
Prior to 2003, Paul held marketing and sales positions of increasing responsibility at Abbott Labs and Merck & Co. Inc.
Born in Brussels, Belgium, Paul earned an MS in Chemical Engineering from University of Brussels in 1985 and an MBA from Carnegie Mellon University in 1987.
He is currently on the Board of Directors of Pharmaceutical Research and Manufacturers of America (PhRMA) and is a member of the New England Chapter of CEO’s Against Cancer serving as Vice Chair. In the past he has served as Chairman of the National Pharmaceutical Council (NPC).
Paul became a US Citizen in 1988, and retains Belgium Citizenship. He currently resides in Westport, CT with his spouse – Nathalie and their three children.